RECRUITINGOBSERVATIONAL
Functional and Quality of Life Improvement Following Transcatheter Heart Valve Implantation
About This Trial
The objective is to observe trends in patient characteristics and outcomes after aortic or mitral transcatheter heart valve replacement over time.
Who May Be Eligible (Plain English)
Who May Qualify:
1. Subject selected for transcatheter heart valve replacement
2. Signed willing to sign a consent form to participate in the study
Who Should NOT Join This Trial:
1. Inability to sign written willing to sign a consent form.
2. Pregnancy or breast feeding (women of childbearing potential will have a serum or urine pregnancy test).
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
1. Subject selected for transcatheter heart valve replacement
2. Signed informed consent to participate in the study
Exclusion Criteria:
1. Inability to sign written informed consent.
2. Pregnancy or breast feeding (women of childbearing potential will have a serum or urine pregnancy test).
Locations (5)
Hadassah Medical Center
Jerusalem, Israel
Shaarei Zedek amedical Center
Jerusalem, Israel
Rabin Medical Center
Petah Tikva, Israel
Sheba Medical Center
Ramat Gan, Israel
Tel Aviv Medical Center
Tel Aviv, Israel